453 related articles for article (PubMed ID: 15972693)
1. 5-aminoimidazole-4-carboxamide ribonucleoside: a novel immunomodulator with therapeutic efficacy in experimental autoimmune encephalomyelitis.
Nath N; Giri S; Prasad R; Salem ML; Singh AK; Singh I
J Immunol; 2005 Jul; 175(1):566-74. PubMed ID: 15972693
[TBL] [Abstract][Full Text] [Related]
2. Potential targets of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor for multiple sclerosis therapy.
Nath N; Giri S; Prasad R; Singh AK; Singh I
J Immunol; 2004 Jan; 172(2):1273-86. PubMed ID: 14707106
[TBL] [Abstract][Full Text] [Related]
3. Immunomodulatory effect of combination therapy with lovastatin and 5-aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside alleviates neurodegeneration in experimental autoimmune encephalomyelitis.
Paintlia AS; Paintlia MK; Singh I; Singh AK
Am J Pathol; 2006 Sep; 169(3):1012-25. PubMed ID: 16936274
[TBL] [Abstract][Full Text] [Related]
4. De novo central nervous system processing of myelin antigen is required for the initiation of experimental autoimmune encephalomyelitis.
Tompkins SM; Padilla J; Dal Canto MC; Ting JP; Van Kaer L; Miller SD
J Immunol; 2002 Apr; 168(8):4173-83. PubMed ID: 11937578
[TBL] [Abstract][Full Text] [Related]
5. 5-aminoimidazole-4-carboxamide-1-beta-4-ribofuranoside attenuates experimental autoimmune encephalomyelitis via modulation of endothelial-monocyte interaction.
Prasad R; Giri S; Nath N; Singh I; Singh AK
J Neurosci Res; 2006 Aug; 84(3):614-25. PubMed ID: 16770773
[TBL] [Abstract][Full Text] [Related]
6. An aza-anthrapyrazole negatively regulates Th1 activity and suppresses experimental autoimmune encephalomyelitis.
Clark MP; Leaman DW; Hazelhurst LA; Hwang ES; Quinn A
Int Immunopharmacol; 2016 Feb; 31():74-87. PubMed ID: 26709219
[TBL] [Abstract][Full Text] [Related]
7. S-nitrosoglutathione a physiologic nitric oxide carrier attenuates experimental autoimmune encephalomyelitis.
Nath N; Morinaga O; Singh I
J Neuroimmune Pharmacol; 2010 Jun; 5(2):240-51. PubMed ID: 20091246
[TBL] [Abstract][Full Text] [Related]
8. Role of IL-12 receptor beta 1 in regulation of T cell response by APC in experimental autoimmune encephalomyelitis.
Zhang GX; Yu S; Gran B; Li J; Siglienti I; Chen X; Calida D; Ventura E; Kamoun M; Rostami A
J Immunol; 2003 Nov; 171(9):4485-92. PubMed ID: 14568921
[TBL] [Abstract][Full Text] [Related]
9. Vasoactive intestinal polypeptide suppressed experimental autoimmune encephalomyelitis by inhibiting T helper 1 responses.
Li H; Mei Y; Wang Y; Xu L
J Clin Immunol; 2006 Sep; 26(5):430-7. PubMed ID: 16964563
[TBL] [Abstract][Full Text] [Related]
10. Peroxisome proliferator-activated receptor-gamma-deficient heterozygous mice develop an exacerbated neural antigen-induced Th1 response and experimental allergic encephalomyelitis.
Natarajan C; Muthian G; Barak Y; Evans RM; Bright JJ
J Immunol; 2003 Dec; 171(11):5743-50. PubMed ID: 14634082
[TBL] [Abstract][Full Text] [Related]
11. IL-4, IL-10, IL-13, and TGF-beta from an altered peptide ligand-specific Th2 cell clone down-regulate adoptive transfer of experimental autoimmune encephalomyelitis.
Young DA; Lowe LD; Booth SS; Whitters MJ; Nicholson L; Kuchroo VK; Collins M
J Immunol; 2000 Apr; 164(7):3563-72. PubMed ID: 10725711
[TBL] [Abstract][Full Text] [Related]
12. Novel anti-inflammatory action of 5-aminoimidazole-4-carboxamide ribonucleoside with protective effect in dextran sulfate sodium-induced acute and chronic colitis.
Bai A; Yong M; Ma AG; Ma Y; Weiss CR; Guan Q; Bernstein CN; Peng Z
J Pharmacol Exp Ther; 2010 Jun; 333(3):717-25. PubMed ID: 20237071
[TBL] [Abstract][Full Text] [Related]
13. The HMG-CoA reductase inhibitor, atorvastatin, promotes a Th2 bias and reverses paralysis in central nervous system autoimmune disease.
Youssef S; Stüve O; Patarroyo JC; Ruiz PJ; Radosevich JL; Hur EM; Bravo M; Mitchell DJ; Sobel RA; Steinman L; Zamvil SS
Nature; 2002 Nov; 420(6911):78-84. PubMed ID: 12422218
[TBL] [Abstract][Full Text] [Related]
14. Pituitary adenylate cyclase-activating polypeptide (PACAP) ameliorates experimental autoimmune encephalomyelitis by suppressing the functions of antigen presenting cells.
Kato H; Ito A; Kawanokuchi J; Jin S; Mizuno T; Ojika K; Ueda R; Suzumura A
Mult Scler; 2004 Dec; 10(6):651-9. PubMed ID: 15584490
[TBL] [Abstract][Full Text] [Related]
15. A novel human truncated IL12rβ1-Fc fusion protein ameliorates experimental autoimmune encephalomyelitis via specific binding of p40 to inhibit Th1 and Th17 cell differentiation.
Guo W; Wang C; Wang X; Luo C; Yu D; Wang Y; Chen Y; Lei W; Gao X; Yao W
Oncotarget; 2015 Oct; 6(30):28539-55. PubMed ID: 26384304
[TBL] [Abstract][Full Text] [Related]
16. Erythropoietin enhances endogenous haem oxygenase-1 and represses immune responses to ameliorate experimental autoimmune encephalomyelitis.
Chen SJ; Wang YL; Lo WT; Wu CC; Hsieh CW; Huang CF; Lan YH; Wang CC; Chang DM; Sytwu HK
Clin Exp Immunol; 2010 Nov; 162(2):210-23. PubMed ID: 21069936
[TBL] [Abstract][Full Text] [Related]
17. Ethanol extract of Glycyrrhizae Radix modulates the responses of antigen-specific splenocytes in experimental autoimmune encephalomyelitis.
Yang EJ; Song IS; Song KS
Phytomedicine; 2019 Feb; 54():56-65. PubMed ID: 30668383
[TBL] [Abstract][Full Text] [Related]
18. Recombinant TCR ligand induces tolerance to myelin oligodendrocyte glycoprotein 35-55 peptide and reverses clinical and histological signs of chronic experimental autoimmune encephalomyelitis in HLA-DR2 transgenic mice.
Vandenbark AA; Rich C; Mooney J; Zamora A; Wang C; Huan J; Fugger L; Offner H; Jones R; Burrows GG
J Immunol; 2003 Jul; 171(1):127-33. PubMed ID: 12816990
[TBL] [Abstract][Full Text] [Related]
19. Peroxisome proliferator-activated receptor-gamma agonists inhibit experimental allergic encephalomyelitis by blocking IL-12 production, IL-12 signaling and Th1 differentiation.
Natarajan C; Bright JJ
Genes Immun; 2002 Apr; 3(2):59-70. PubMed ID: 11960303
[TBL] [Abstract][Full Text] [Related]
20. Five-aminoimidazole-4-carboxamide-1-beta-4-ribofuranoside attenuates poly (I:C)-induced airway inflammation in a murine model of asthma.
Kim TB; Kim SY; Moon KA; Park CS; Jang MK; Yun ES; Cho YS; Moon HB; Lee KY
Clin Exp Allergy; 2007 Nov; 37(11):1709-19. PubMed ID: 17877757
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
